(Q53146233)

11 May 2018

title

Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). (English)

1 reference

11 May 2018

randomized controlled trial

main subject

1 reference

inferred from title

author

Marie-Louise Essink-Bot

2

1 reference

11 May 2018

author name string

Karien A M van den Bergh

1

1 reference

11 May 2018

Eveline M Bunge

3

1 reference

11 May 2018

Ernst Th Scholten

4

1 reference

11 May 2018

Mathias Prokop

5

1 reference

11 May 2018

Carola A van Iersel

6

1 reference

11 May 2018

Rob J van Klaveren

7

1 reference

11 May 2018

Harry J de Koning

8

1 reference

11 May 2018

language of work or name

English

0 references

publication date

1 July 2008

1 reference

11 May 2018

published in

Cancer

1 reference

11 May 2018

volume

113

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

396-404

1 reference

11 May 2018

Survival of patients with stage I lung cancer detected on CT screening

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Computed tomography screening and lung cancer outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Nodule management protocol of the NELSON randomised lung cancer screening trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

The burden of upper gastrointestinal endoscopy in patients with Barrett’s esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Short-term effects of population-based screening for prostate cancer on health-related quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Assessing psychosocial/quality of life outcomes in screening: how do we do it better?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Generalizability of valuations on health states collected with the EuroQolc-questionnaire.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Modeling valuations for EuroQol health states

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Impact of Event Scale: A Measure of Subjective Stress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Short-term impact of cancer prevention and screening activities on quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Impact of screening for breast cancer in high-risk women on health-related quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Smoking and SF-36 health functioning.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Positive psychological states and coping with severe stress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Decreasing women's anxieties after abnormal mammograms: a controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Validation of a condition-specific measure for women having an abnormal screening mammography.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23590

7 January 2021

Identifiers

DOI

10.1002/CNCR.23590

1 reference

11 May 2018

1 reference

11 May 2018